Dynamic Pituitary-Adrenal Interactions in the Critically Ill after Cardiac Surgery.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 13 09 2019
accepted: 15 11 2019
pubmed: 19 11 2019
medline: 10 2 2021
entrez: 19 11 2019
Statut: ppublish

Résumé

Patients with critical illness are thought to be at risk of adrenal insufficiency. There are no models of dynamic hypothalamic-pituitary-adrenal (HPA) axis function in this group of patients and thus current methods of diagnosis are based on aggregated, static models. To characterize the secretory dynamics of the HPA axis in the critically ill (CI) after cardiac surgery. Mathematical modeling of cohorts. Cardiac critical care unit. 20 male patients CI at least 48 hours after cardiac surgery and 19 healthy (H) male volunteers. None. Measures of hormone secretory dynamics were generated from serum adrenocorticotrophic hormone (ACTH) sampled every hour and total cortisol every 10 min for 24 h. All CI patients had pulsatile ACTH and cortisol profiles. CI patients had similar ACTH secretion (1036.4 [737.6] pg/mL/24 h) compared to the H volunteers (1502.3 [1152.2] pg/mL/24 h; P = .20), but increased cortisol secretion (CI: 14 447.0 [5709.3] vs H: 5915.5 [1686.7)] nmol/L/24 h; P < .0001). This increase in cortisol was due to nonpulsatile (CI: 9253.4 [3348.8] vs H: 960 [589.0] nmol/L/24 h, P < .0001), rather than pulsatile cortisol secretion (CI: 5193.1 [3018.5] vs H: 4955.1 [1753.6] nmol/L/24 h; P = .43). Seven (35%) of the 20 CI patients had cortisol pulse nadirs below the current international guideline threshold for critical illness-related corticosteroid insufficiency, but an overall secretion that would not be considered deficient. This study supports the premise that current tests of HPA axis function are unhelpful in the diagnosis of adrenal insufficiency in the CI. The reduced ACTH and increase in nonpulsatile cortisol secretion imply that the secretion of cortisol is driven by factors outside the HPA axis in critical illness.

Identifiants

pubmed: 31738827
pii: 5628812
doi: 10.1210/clinem/dgz206
pmc: PMC7089849
pii:
doi:

Substances chimiques

Adrenocorticotropic Hormone 9002-60-2
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : British Heart Foundation
ID : PG/14/72/31080
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J015350/1
Pays : United Kingdom
Organisme : Department of Health
ID : EME/15/180/55
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1992027/7163
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/13/9/29990
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/11/19/28827
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Endocrinol Invest. 2006 Dec;29(11):983-8
pubmed: 17259795
Cochrane Database Syst Rev. 2015 Dec 03;(12):CD002243
pubmed: 26633262
J Clin Endocrinol Metab. 2009 Oct;94(10):4045-52
pubmed: 19755477
J Intensive Care Soc. 2017 May;18(2):121-129
pubmed: 28979558
Curr Biol. 2007 Sep 4;17(17):R746-51
pubmed: 17803920
Crit Care Med. 2017 Dec;45(12):2089-2098
pubmed: 28938251
Crit Care Med. 2017 Dec;45(12):2078-2088
pubmed: 28938253
Nat Rev Neurosci. 2010 Oct;11(10):710-8
pubmed: 20842176
J Hepatol. 2010 Jun;52(6):839-45
pubmed: 20385427
Lancet Diabetes Endocrinol. 2015 Oct;3(10):805-15
pubmed: 26071883
Intensive Care Med. 2015 Jan;41(1):131-3
pubmed: 25406407
Can J Anaesth. 2018 Sep;65(9):985-995
pubmed: 29858989
Crit Care. 2017 Mar 28;21(1):78
pubmed: 28351429
Crit Care Med. 2015 Apr;43(4):791-800
pubmed: 25517478
Am J Physiol Regul Integr Comp Physiol. 2010 Jul;299(1):R11-8
pubmed: 20410472
N Engl J Med. 2013 Apr 18;368(16):1477-88
pubmed: 23506003
Crit Care Med. 2017 Oct;45(10):e1103-e1104
pubmed: 28915200
Neuroendocrinology. 1989 Aug;50(2):124-31
pubmed: 2550834
J Physiol. 1987 Sep;390:23-31
pubmed: 2832590
Proc Biol Sci. 2010 Jun 7;277(1688):1627-33
pubmed: 20129987
Crit Care Med. 1994 May;22(5):833-7
pubmed: 8181293
J Med Eng Technol. 2009;33(3):199-208
pubmed: 19340690
Am J Physiol Endocrinol Metab. 2003 Nov;285(5):E938-48
pubmed: 14534073
PLoS Biol. 2012;10(6):e1001341
pubmed: 22679394
Eur J Endocrinol. 1994 Nov;131(5):443-50
pubmed: 7952154
J Theor Biol. 2005 Oct 7;236(3):242-55
pubmed: 15916772
N Engl J Med. 1995 May 18;332(20):1351-62
pubmed: 7715646
Clin Endocrinol (Oxf). 2014 Aug;81(2):289-93
pubmed: 24735400
J Clin Endocrinol Metab. 2020 Apr 1;105(4):
pubmed: 31529059
Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E883-92
pubmed: 24569590
J Clin Endocrinol Metab. 1995 Apr;80(4):1238-42
pubmed: 7714094
J Neuroendocrinol. 2010 Oct;22(10):1093-1100
pubmed: 20649850
Horm Metab Res. 2011 Sep;43(10):714-9
pubmed: 21932176
Clin Chem. 2004 Apr;50(4):757-9
pubmed: 15044334
J Clin Endocrinol Metab. 2009 Nov;94(11):4234-42
pubmed: 19820009
Physiology (Bethesda). 2016 Jan;31(1):34-50
pubmed: 26674550
J Med Eng Technol. 2013 Apr;37(3):180-4
pubmed: 23547774
Am J Physiol. 1989 Jul;257(1 Pt 1):E6-14
pubmed: 2750897
Endocr Connect. 2017 Oct;6(7):500-509
pubmed: 28760748
Sleep Med Rev. 2010 Aug;14(4):269-80
pubmed: 20056462
J Endocrinol Invest. 2003;26(7 Suppl):2-14
pubmed: 14604061
Intensive Care Med. 2012 May;38(5):804-10
pubmed: 22286671
J Neuroendocrinol. 2010 Dec;22(12):1226-38
pubmed: 21054582
Surg Gynecol Obstet. 1990 Jun;170(6):513-6
pubmed: 2343366
J Clin Endocrinol Metab. 1998 Apr;83(4):1247-52
pubmed: 9543150
J Physiol. 1987 Jan;382:385-96
pubmed: 3040966

Auteurs

Ben Gibbison (B)

Department of Anaesthesia, Bristol Medical School, University of Bristol, Bristol, UK.

Daniel M Keenan (DM)

Department of Statistics, University of Virginia, Charlottesville, VA, US.

Ferdinand Roelfsema (F)

Department of Internal Medicine, Section Endocrinology, University of Leiden, Leiden, The Netherlands.

Jon Evans (J)

Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK.

Kirsty Phillips (K)

Department of Pathology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Chris A Rogers (CA)

Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK.

Gianni D Angelini (GD)

Department of Cardiac Surgery, Bristol Medical School, University of Bristol, Bristol, UK.

Stafford L Lightman (SL)

Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH